ID.16. Developing human antibodies into imaging and therapeutic agents for cardiovascular disease
- Línea de investigación
- Nanomedicine & Molecular Imaging.
- Título
- Developing human antibodies into imaging and therapeutic agents for cardiovascular disease.
- Descripción
- The ultimate goal of our research is to develop fully human antibodies (HuAbs) into diagnostic tools and personalized therapeutic agents to treat atherosclerosis. HuAbs selected in vivo from atherosclerotic samples are characterized and produced in different formats suitable for therapeutic purposes or imaging with positron emission tomography (PET). In vivo testing of HuAb-based therapies and PET radiotracers is carried out in animal models of atherosclerosis.
- Tutor
- Carlos Pérez Medina.
- Centro
- Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC).
- Contacto
- cperez@cnic.es
- Número de plazas ofertadas
- 2.